Schroders PLC has reduced its holding in Tigermed Consulting Co., Ltd. (03347) by 579,300 shares at an average price of approximately HKD 35.87 per share.

On May 14, Schroders PLC reduced its holding in Tigermed Consulting (03347) by 579,300 shares at a price of 35.8726 Hong Kong dollars per share, with a total value of approximately 20.781 million Hong Kong dollars.

Zhitong FinanceMay 15 20:35

Tigermed (03347.HK) received an increase of 1,088,100 H-shares from Xingzheng Global Fund Management Co., Ltd., valued at approximately HKD 38.92 million.

According to a report on May 15, in a document disclosed by the Hong Kong Stock Exchange on May 15, Xingzheng Global Fund Management Co., Ltd. increased its holdings of 1.0881 million H-shares of $Tigermed (03347.HK)$ at an average price of 35.7647 Hong Kong dollars per share on May 13, with a total value of approximately 38.9156 million Hong Kong dollars. After the increase, the total number of shares held by Xingzheng Global Fund Management Co., Ltd. reached 7.0934 million shares, and the long position ratio rose from 4.88% to 5.76%. Image Source: HKEX Equity Disclosure. What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (those holding 5% or more...

Futu NewsMay 15 17:10

Tigermed (03347.HK) was increased in holdings by Xingzheng Global Fund Management Co., Ltd. with an additional 719,300 H-shares, valued at approximately HKD 25.84 million.

According to a report on May 15, based on the document disclosed by the Hong Kong Stock Exchange on May 15, Xingzheng Global Fund Management Co., Ltd. increased its holdings of 719,300 H shares of Tigermed Consulting Co., Ltd. (Stock Code: 03347.HK) at an average price of HKD 35.9267 per share on May 14, with a total value of approximately HKD 25,842,100. After the increase, Xingzheng Global Fund Management Co., Ltd.'s total number of shares held reached 7,812,700, and its long position ratio rose from 5.76% to 6.35%. Source of image: Equity Disclosure of the Stock Exchange. What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (those holding 5% or more of shares...

Futu NewsMay 15 17:10

Tigermed Consulting Launches 1 Billion Yuan Stock Buyback

MT NewswiresMay 14 10:33

Major Bank Ratings | Citi: The fundamentals of Tigermed have not been affected; view the stock's weakness as a buying opportunity, with a target price of 67 yuan.

Citi issued a research report stating that Tigermed Consulting disclosed that its co-founders and actual controllers, Ye Xiaoping and Cao Xiaochun, received formal investigation notices from the China Securities Regulatory Commission (CSRC) for failing to promptly disclose changes in their shareholding during the period from December 2014 to May 2026, after their shareholding ratio decreased by more than 10 percentage points. Citi believes this constitutes a violation of compliance procedures, with the most likely outcome being a warning and a fine, pending clarification of the penalty. The bank believes that the incident will not impact the company's fundamentals and views any weakness in the stock price as an enhanced buying opportunity. The bank has set a target price of 67 yuan for Tigermed Consulting’s A-shares and maintains a 'Buy' rating.

Gelonghui FinanceMay 14 10:27 · Ratings

TigerMed receives an increase of 813,800 shares purchased by Norges Bank at approximately HKD 38.65 per share.

According to the latest data from the Hong Kong Stock Exchange, on May 8, Norges Bank increased its holdings in Tigermed (03347) by 813,800 shares at a price of HKD 38.6523 per share, with a total value of approximately HKD 31.46 million. After the increase, the total number of shares held is approximately 6,494,100, representing a stake of 5.27%.

Sina Hong Kong StocksMay 14 07:52